Search Results 151-160 of 18364 for crohn's disease

  1. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    Understanding of how best to treat inflammatory bowel disease (IBD) ... Evidence now suggests that the most effective therapy early in the course of Crohn's ...

  2. Promising Application for Stem Cells: Crohn's Complications

    ... Crohn's disease patients. Their extreme pain from complications is both physical and emotional and, for many, incurable. But, an innovation using the ...

  3. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  4. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

  5. Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease - Mayo Clinic

    The purpose of this study is to determine the effectiveness of RPC1063 in the initial treatment of moderate to severely active Crohn's disease. Participation ...

  6. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    This study will evaluate the efficacy and safety of two adalimumab induction regimens in subjects with moderately to severely active Crohn's disease and ...

  7. Digestive Diseases News - Medical Professionals - Mayo Clinic

    Five individuals with inflammatory bowel disease (IBD) and obesity experienced effective weight loss after endoscopic bariatric therapy (EBT). April 21, 2023 ...

  8. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  9. Infliximab (intravenous route) - Mayo Clinic

    Infliximab injection is used to reduce the symptoms of moderate-to-severely active Crohn's ... Some teenagers and young adults with Crohn disease or ulcerative ...

  10. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing ...